breast hyperplasia
Conditions
Interventions
control group:Tamoxifen tablets
Treatment group:Rutongning II
Sponsors
Hanzhong Traditional Chinese Medicine Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 50 Years
Inclusion criteria
Inclusion criteria: Satisfy Western medical diagnosis. Meet the traditional Chinese medicine syndrome differentiation criteria. Women between the ages of 18 and 50. I have not used any method to treat this disease in the past month. I have not used any sex hormone preparations or products in the past six months. Sign the informed consent form voluntarily participate and follow the relevant regulations during the process.
Exclusion criteria
Exclusion criteria: Those with severe irregular menstrual periods and menstrual periods lasting more than 7 days. Those who are currently in pregnancy lactation or menopause. At the same time there are other breast diseases present. Individuals with severe liver and kidney damage cardiovascular and cerebrovascular diseases endocrine disorders and other systemic diseases. Individuals with mental and behavioral disorders who are unable to sign informed consent forms. Individuals with high allergy constitution are known to be allergic to the herbal plants in this formula. Participants in other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Range of lump before and after treatment;BI-RADS grading of nodules before and after treatment;Tumor diameter before and after treatment; | — |
Secondary
| Measure | Time frame |
|---|---|
| Pain and subjective pain rating;Changes in glandular thickness;Improvement of Traditional Chinese Medicine Syndrome Points; | — |
Countries
China
Contacts
Public ContactJungang Huang
Hanzhong Traditional Chinese Medicine Hospital
Outcome results
None listed